L. Leibovici

568 total citations
8 papers, 386 citations indexed

About

L. Leibovici is a scholar working on Epidemiology, Pharmacology and Oncology. According to data from OpenAlex, L. Leibovici has authored 8 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 2 papers in Pharmacology and 2 papers in Oncology. Recurrent topics in L. Leibovici's work include Urinary Tract Infections Management (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). L. Leibovici is often cited by papers focused on Urinary Tract Infections Management (2 papers), Sepsis Diagnosis and Treatment (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). L. Leibovici collaborates with scholars based in Israel. L. Leibovici's co-authors include Luisa Bonilla, Laura Vidal, Irit Ben‐Aharon, Salomon M. Stemmer, Anat Gafter‐Gvili, Mical Paul, Dafna Yahav, Jihad Bishara, Ami Neuberger and Nesrin Ghanem‐Zoubi and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Diabetes and Clinical Infectious Diseases.

In The Last Decade

L. Leibovici

8 papers receiving 375 citations

Peers

L. Leibovici

EPIDE

ONCOL

CR

ID

CB

Constance Keyserling United States

Thomas M. Elliott Australia

Cynthia Macahilig United States

Shawn Dason United States

Kylie Snook Australia

S. Roy United States

Helene Skjøt‐Arkil Denmark

Kibum Jeon South Korea

Ruibin Wang United States

N. Germann France

Constance Keyserling United States

L. Leibovici

240 ×1.8

EPIDE

32 ×0.3

ONCOL

132 ×1.4

CR

143 ×2.0

ID

39 ×0.6

CB

Citations per year, relative to L. Leibovici L. Leibovici (= 1×) peers Constance Keyserling

Countries citing papers authored by L. Leibovici

Since Specialization

Citations

This map shows the geographic impact of L. Leibovici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Leibovici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Leibovici more than expected).

Fields of papers citing papers by L. Leibovici

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Leibovici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Leibovici. The network helps show where L. Leibovici may publish in the future.

Co-authorship network of co-authors of L. Leibovici

This figure shows the co-authorship network connecting the top 25 collaborators of L. Leibovici. A scholar is included among the top collaborators of L. Leibovici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Leibovici. L. Leibovici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Paul, Mical, Jihad Bishara, Dafna Yahav, et al.. (2015). Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial. BMJ. 350(may14 24). h2219–h2219. 101 indexed citations

2.

Leibovici, L., Galia Kariv, & Mical Paul. (2013). Long-term survival in patients included in a randomized controlled trial of TREAT, a decision support system for antibiotic treatment. Journal of Antimicrobial Chemotherapy. 68(11). 2664–2666. 23 indexed citations

3.

Yahav, Dafna, Adi Lador, Monika Paul-Samojedny, & L. Leibovici. (2011). Efficacy and safety of tigecycline: a systematic review and meta-analysis--authors' responses. Journal of Antimicrobial Chemotherapy. 66(12). 2895–2896. 3 indexed citations

4.

Bonilla, Luisa, Irit Ben‐Aharon, Laura Vidal, et al.. (2010). Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. JNCI Journal of the National Cancer Institute. 102(24). 1845–1854. 144 indexed citations

5.

Milo, Gai, et al.. (2006). Duration of Antibacterial Treatment for Uncomplicated Urinary Tract Infection in Women. The Journal of Urology. 175(3). 968–968. 36 indexed citations

6.

Ashkenazi, Shai, L. Leibovici, Zmira Samra, H. Konisberger, & M. Drucker. (1992). Risk Factors for Mortality Due to Bacteremia and Fungemia in Childhood. Clinical Infectious Diseases. 14(4). 949–951. 29 indexed citations

7.

Leibovici, L., et al.. (1991). Single-dose Antibiotic Treatment for Symptomatic Urinary Tract Infections in Women: a Meta-analysis of Randomized Trials. QJM. 33 indexed citations

8.

Leibovici, L., et al.. (1991). Risk factors for development of diabetic nephropathy and retinopathy in Jewish IDDM patients. Diabetes. 40(2). 204–210. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact